Abstract
This paper describes the role of gamma-hydroxybutyric acid (GHB) in the treatment of opiate withdrawal syndrome. In the two patients described, after having abruptly withdrawn from long-term methadone treatment, GHB was orally administered (each dose given every 4–6 h) for 8–9 days. The GHB showed both a high efficacy (some mild and transient symptoms attributable to opiate withdrawal were observed, but only in the first days of therapy) and a good tolerability (no clinical phenomena interpreted as GHB side effects were found). These results could be of interest in improving the pharmacological treatment of drug addiction.
Similar content being viewed by others
References
Mandel P, Maitre M, Vayer P, Hechler V (1987) Function of gammahydroxybutyrate: a putative neurotransmitter. Biochem Soc Trans 15:215–216
Fadda F, Argiolas A, Melis MR, De Montis G, Gessa GL (1989) Suppression of voluntary ethanol consumption in rats by gamma-butyrolactone. Life Sci 32:1471–1477
Fadda F, Mosca E, Colombo G, Gessa GL (1989) Suppression by gamma-hydroxy-butyric acid of ethanol withdrawal syndrome in rats. Alcohol Alcohol 24:447–451
Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Fadda F, Ferrara SD, Gessa GL (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet II: 787–789
Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL (1992) Gamma-hydroxy-butyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol Clin Exp Res 16:673–676
Wang RIH, Wiesen RL, Lamid S (1974) Rating the presence of opiate dependence. Clin Pharmacol Ther 16:653–658
Ferrara SD, Gessa GL, Gallimberti L (1992) Farmacotossicologia e farmacocinetica del GHB. In: Gallimberti L, Ferrara SD, Gessa GL (eds) Il GHB nel trattamento della dipendenza alcolica. ARFI, Padova
Food and Drug Administration. Gamma-hydroxybutyric acid (press release). Food and Drug Administration, November 8th, 1990, Rockville, Maryland
Gessa GL (1991) Le basi biologiche della cosiddetta dipendenza psichica. Fed Medica 44:641–644
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gallimberti, L., Schifano, F., Forza, G. et al. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur Arch Psychiatry Clin Nuerosci 244, 113–114 (1994). https://doi.org/10.1007/BF02191883
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02191883